Literature DB >> 11560514

Erythrocyte spectrin is an E2 ubiquitin conjugating enzyme.

D G Kakhniashvili1, T Chaudhary, W E Zimmer, F A Bencsath, I Jardine, S R Goodman.   

Abstract

The involvement of red blood cell spectrin in the ubiquitination process was studied. Spectrin was found to form two ubiquitin-associated derivatives, a DTT-sensitive ubiquitin adduct and a DTT-insensitive conjugate, characteristic intermediate and final products of the ubiquitination reaction cascade. In addition to spectrin and ubiquitin, ubiquitin-activating enzyme (E1) and ATP were necessary and sufficient to form both the spectrin-ubiquitin adduct and conjugate. No exogenous ubiquitin-conjugating (E2) or ligase (E3) activities were required, suggesting that erythrocyte spectrin is an E2 ubiquitin-conjugating enzyme able to target itself. Both ubiquitin adduct and conjugate were linked to the alpha subunit of spectrin, suggesting that the ubiquitin-conjugating (UBC) domain and its target regions reside on the same subunit.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11560514     DOI: 10.1021/bi010176t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Spectrin's chimeric E2/E3 enzymatic activity.

Authors:  Steven R Goodman; Rachel Petrofes Chapa; Warren E Zimmer
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

2.  Dysfunction of the β2-spectrin-based pathway in human heart failure.

Authors:  Sakima A Smith; Langston D Hughes; Crystal F Kline; Amber N Kempton; Lisa E Dorn; Jerry Curran; Michael Makara; Tyler R Webb; Patrick Wright; Niels Voigt; Philip F Binkley; Paul M L Janssen; Ahmet Kilic; Cynthia A Carnes; Dobromir Dobrev; Matthew N Rasband; Thomas J Hund; Peter J Mohler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-22       Impact factor: 4.733

Review 3.  The Spectrinome: The Interactome of a Scaffold Protein Creating Nuclear and Cytoplasmic Connectivity and Function.

Authors:  Steven R Goodman; Daniel Johnson; Steven L Youngentob; David Kakhniashvili
Journal:  Exp Biol Med (Maywood)       Date:  2019-09-04

Review 4.  Spectrin and its interacting partners in nuclear structure and function.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2018-03

5.  Toxicogenomics profiling of bone marrow from rats treated with topotecan in combination with oxaliplatin: a mechanistic strategy to inform combination toxicity.

Authors:  Myrtle Davis; Jianying Li; Elaine Knight; Sandy R Eldridge; Kellye K Daniels; Pierre R Bushel
Journal:  Front Genet       Date:  2015-02-12       Impact factor: 4.599

Review 6.  The Role of Nonerythroid Spectrin αII in Cancer.

Authors:  Anne Ackermann; Angela Brieger
Journal:  J Oncol       Date:  2019-05-02       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.